Trial investigators report lower risks for skeletal-related events, hospitalization, and death. Prophylactic radiation therapy for high-risk asymptomatic bone metastases lowers risks for adverse outcomes.
Trial investigators report lower risks for skeletal-related events, hospitalization, and death. Prophylactic radiation therapy for high-risk asymptomatic bone metastases lowers risks for adverse outcomes.
American Society for Radiation Oncology, Oct 23-26 kxly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kxly.com Daily Mail and Mail on Sunday newspapers.
Prophylactic radiotherapy for asymptomatic bone metastases could become standard of care after a randomized trial showed that it improved overall survival as well as reducing skeletal-related events.
Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations and possibly extend overall survival in people whose cancer has spread to multiple sites, a phase II clinical trial suggests.